Core Viewpoint - iRadimed (IRMD) reported quarterly earnings of $0.49 per share, exceeding the Zacks Consensus Estimate of $0.45 per share, and showing an increase from $0.42 per share a year ago, indicating a positive earnings surprise of +8.89% [1] Group 1: Earnings Performance - The company achieved revenues of $20.41 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.49% and up from $17.93 million year-over-year [2] - Over the last four quarters, iRadimed has exceeded consensus EPS estimates two times and topped consensus revenue estimates four times [2] Group 2: Stock Performance and Outlook - iRadimed shares have increased approximately 6.1% since the beginning of the year, while the S&P 500 has gained 7.8% [3] - The company's earnings outlook will be crucial for future stock performance, with current consensus EPS estimates at $0.44 for the upcoming quarter and $1.76 for the current fiscal year [7] Group 3: Industry Context - The Medical - Instruments industry, to which iRadimed belongs, is currently ranked in the bottom 37% of over 250 Zacks industries, which may impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that investors should monitor these revisions closely [5]

Financial Performance - Dominion Energy reported quarterly earnings of $0.75 per share, exceeding the Zacks Consensus Estimate of $0.69 per share, and up from $0.55 per share a year ago, representing an earnings surprise of +8.70% [1] - The company posted revenues of $3.81 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4.54%, compared to $3.49 billion in the same quarter last year [2] - Over the last four quarters, Dominion Energy has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Stock Performance - Dominion Energy shares have increased approximately 8.5% since the beginning of the year, outperforming the S&P 500's gain of 7.8% [3] - The current Zacks Rank for Dominion Energy is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.14 on revenues of $4.08 billion, and for the current fiscal year, it is $3.39 on revenues of $15.24 billion [7] - The outlook for the Utility - Electric Power industry is positive, currently ranking in the top 33% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8]

Moderna (MRNA) came out with a quarterly loss of $2.13 per share versus the Zacks Consensus Estimate of a loss of $2.99. This compares to a loss of $3.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +28.76%. A quarter ago, it was expected that this biotechnology company would post a loss of $2.92 per share when it actually produced a loss of $2.52, delivering a surprise of +13.7%.Over the last four quarters, the company has ...

分组1 - LyondellBasell reported quarterly earnings of $0.62 per share, missing the Zacks Consensus Estimate of $0.87 per share, and down from $2.24 per share a year ago, representing an earnings surprise of -28.74% [1] - The company posted revenues of $7.66 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.41%, but down from $10.56 billion year-over-year [2] - LyondellBasell shares have declined approximately 22% since the beginning of the year, contrasting with the S&P 500's gain of 7.8% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $1.16 on revenues of $7.34 billion, and for the current fiscal year, it is $3.50 on revenues of $29.79 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 5% of over 250 Zacks industries, indicating a challenging environment for the sector [8] - The estimate revisions trend for LyondellBasell was unfavorable ahead of the earnings release, resulting in a Zacks Rank 5 (Strong Sell) for the stock [6]

Core Viewpoint - Regeneron reported strong quarterly earnings of $12.89 per share, significantly exceeding the Zacks Consensus Estimate of $8.03 per share, marking an earnings surprise of +60.52% [1][2] Financial Performance - The company achieved revenues of $3.68 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 9.91% and showing an increase from $3.55 billion year-over-year [2] - Over the last four quarters, Regeneron has exceeded consensus EPS estimates three times and has also topped consensus revenue estimates three times [2] Stock Performance - Regeneron shares have declined approximately 23.4% since the beginning of the year, contrasting with the S&P 500's gain of 7.8% [3] - The current Zacks Rank for Regeneron is 4 (Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $9.18 on revenues of $3.53 billion, while the estimate for the current fiscal year is $35.73 on revenues of $13.67 billion [7] - The trend of estimate revisions prior to the earnings release was unfavorable, which may impact future stock performance [6] Industry Context - The Medical - Biomedical and Genetics industry, to which Regeneron belongs, is currently in the top 40% of Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8]

Company Performance - Butterfly Network, Inc. reported a quarterly loss of $0.06 per share, which was better than the Zacks Consensus Estimate of a loss of $0.07, representing an earnings surprise of +14.29% [1] - The company posted revenues of $23.38 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 2%, but showing an increase from $21.49 million year-over-year [2] - Over the last four quarters, Butterfly Network has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Stock Movement and Outlook - Butterfly Network shares have declined approximately 45.2% since the beginning of the year, contrasting with the S&P 500's gain of 7.8% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is -$0.07 on revenues of $24.42 million, and for the current fiscal year, it is -$0.27 on revenues of $97.39 million [7] Industry Context - The Medical Info Systems industry, to which Butterfly Network belongs, is currently ranked in the top 23% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Butterfly Network's stock performance [5]

Group 1 - Standex International (SXI) reported quarterly earnings of $2.28 per share, exceeding the Zacks Consensus Estimate of $2.1 per share, and showing an increase from $1.76 per share a year ago, representing an earnings surprise of +8.57% [1] - The company achieved revenues of $222.05 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.55%, and up from $180.19 million year-over-year [2] - Over the last four quarters, Standex has consistently surpassed consensus EPS estimates four times and revenue estimates three times [2] Group 2 - The stock has underperformed, losing about 11.7% since the beginning of the year, while the S&P 500 has gained 8.2% [3] - The current consensus EPS estimate for the upcoming quarter is $1.90 on revenues of $207.02 million, and for the current fiscal year, it is $8.69 on revenues of $883.47 million [7] - The Zacks Industry Rank for Manufacturing - General Industrial is in the top 10% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

Core Insights - Northern Oil and Gas (NOG) reported quarterly earnings of $1.37 per share, exceeding the Zacks Consensus Estimate of $0.87 per share, but down from $1.46 per share a year ago, representing an earnings surprise of +57.47% [1] - The company achieved revenues of $574.37 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 10.64% and showing an increase from $561.03 million year-over-year [2] - The stock has underperformed the market, losing about 23% since the beginning of the year compared to the S&P 500's gain of 8.2% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.90 on revenues of $529.57 million, and for the current fiscal year, it is $4.29 on revenues of $2.18 billion [7] - The estimate revisions trend for Northern Oil and Gas was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Oil and Gas - Exploration and Production - United States industry is currently ranked in the bottom 35% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8] - California Resources Corporation (CRC), another company in the same industry, is expected to report quarterly earnings of $0.91 per share, reflecting a year-over-year change of +51.7% [9]

Company Performance - eXp World Holdings (EXPI) reported quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.12 per share, and down from $0.08 per share a year ago, representing an earnings surprise of -50.00% [1] - The company posted revenues of $1.31 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.78%, compared to revenues of $1.3 billion a year ago [2] - Over the last four quarters, eXp World Holdings has not surpassed consensus EPS estimates, and it has topped consensus revenue estimates two times [2] Stock Outlook - eXp World Holdings shares have lost about 5.8% since the beginning of the year, while the S&P 500 has gained 8.2% [3] - The current consensus EPS estimate for the coming quarter is $0.09 on $1.21 billion in revenues, and for the current fiscal year, it is $0.22 on $4.53 billion in revenues [7] - The estimate revisions trend for eXp World Holdings was unfavorable ahead of the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Real Estate - Operations industry, to which eXp World Holdings belongs, is currently in the top 32% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor decisions [5]

Core Insights - Forrester Research reported quarterly earnings of $0.51 per share, exceeding the Zacks Consensus Estimate of $0.50 per share, but down from $0.68 per share a year ago, indicating an earnings surprise of +2.00% [1] - The company posted revenues of $111.66 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.55%, but down from $121.82 million year-over-year [2] - Forrester Research shares have declined approximately 38.1% year-to-date, contrasting with the S&P 500's gain of 8.2% [3] Earnings Outlook - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $0.32 on revenues of $100.58 million, and for the current fiscal year, it is $1.27 on revenues of $406.54 million [7] Industry Context - The Computer - Services industry, to which Forrester Research belongs, is currently ranked in the top 39% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - Another company in the same industry, PDF Solutions, is expected to report quarterly earnings of $0.20 per share, reflecting a year-over-year change of +11.1%, with revenues anticipated to be $53 million, up 27.2% from the previous year [9][10]